Floating Button
Home Capital Broker's Calls

Analysts up Genting Singapore's target price following MBS's 1QFY2023 outperformance

Jovi Ho
Jovi Ho • 5 min read
Analysts up Genting Singapore's target price following MBS's 1QFY2023 outperformance
GENS is expected to report its 1QFY2023 figures in mid-May. Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts remained positive on Genting Singapore (GENS) (SGX:G13) after Las Vegas Sands (LVS) reported its results for the 1QFY2023 ended March 31.

The ebitda recovery trajectory at Marina Bay Sands (MBS) in 1QFY2023 ended March positively surprised the market, say Citi Research analysts George Choi and Ryan Cheung.

Extrapolating from MBS’s performance, Choi and Cheung expect rival GENS's Resorts World Sentosa (RWS) to enjoy a similar recovery during the quarter.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.